M. Meijer

Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype

M. Meijer, Marij A.C. Mieremet-Ooms, Annie M. van der Zon et al. · Digestive and Liver Disease · 2007 · 141 citations

Inflammation, Disease Phenotype, Mucosal Immunology +9

Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases

Qiang Gao, M. Meijer, F J G M Kubben et al. · Digestive and Liver Disease · 2005 · 136 citations

Inflammation, Chronic Inflammatory Diseases, Intestinal Tissue +10

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer

F J G M Kubben, Cornelis F.M. Sier, M. Meijer et al. · British Journal of Cancer · 2006 · 115 citations · Full text

Timp Gene Polymorphisms, Gastrointestinal Oncology, Medicine +8

Effect of the anti-tumor necrosis factor-α antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease

M. Meijer, Marij A.C. Mieremet-Ooms, W. van Duijn et al. · Inflammatory Bowel Diseases · 2006 · 77 citations · Full text

Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohnʼs disease

Qiang Gao, M. Meijer, Ulrike G. Schlüter et al. · Inflammatory Bowel Diseases · 2007 · 57 citations · Full text